Descriptive Report of Microorganisms Detected in Cultures of COVID-19 Patients Developing Secondary Infection After Tocilizumab Use
Tocilizumab an anti-inflammatory medication previously approved for the treatment of rheumatoid arthritis, was widely used during the COVID-19 pandemic. Secondary infections following the use of tocilizumab were expected knowing its inhibitory effect on the cascade of inflammation by blocking IL6. P...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Shiraz University of Medical Sciences,
2024-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|